In the Driver’s Seat With EGFR: Application of Mutation Testing to Treatment Selection for NSCLC @achlcme #NSCLC

Cancer News Photo

Cancer News
1 year 18 Views

This series offers two interactive programs supported by audio and video commentary, where Dr. Justin Gainor and Dr. Maria Arcila share insights on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence in order to help clinicians:


• Increase implementation of best practices for EGFR mutation testing in patients with NSCLC

• Apply clinical trial data to treatment selection in patients with EGFR-mutant NSCLC

• Understand the role of concurrent mutations, such as TP53, in the prognosis and response to therapy of patients with EGFR-mutant NSCLC


To learn more and participate in the activities, visit: